Plumb Pharmaceuticals produces super-extended-release formulations of weak-base, small-molecule pharmaceuticals using creative Quantload technologies that were developed by the company. By providing stimulants for the treatment of ADHD, anti-HIV medications, antibiotics, antipsychotics, cancer chemotherapeutic agents, antihistamines, and analgesics, the company's lipid nanoparticle technology enables the healthcare sector to enhance people's health.